I n an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top executives met, like they had dozens of times before, to hear the ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

Four months after ditching its lead drug, a small Peninsula biotech with less than $40 million on hand hopes to rev up ...

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

Introducing our In Focus on organ-on-a-chip (OoC) technology in drug development, this video explores what OoCs are, how they ...

Drug discovery and development together are the complete process of identifying a new drug and bringing it to market. Discovery may involve screening of chemical libraries, identification of the ...

Regulatory agencies are still developing guidelines for overseeing AI applications in drug development, leading to uncertainty that may hinder innovation. 9 Addressing the challenges of ...